Log in
Biochemistry · Heme Metabolism and Iron Metabolism

Porphyrias

Porphyria

Porphyrias are a group of disorders caused by genetic defects or dysregulation of enzymes in the heme biosynthesis pathway. The main issue in this pathology lies not in the deficiency of the final product itself, but in the massive accumulation of toxic intermediate metabolites.

EtiologyHereditary defects in heme synthesis enzyme genes or regulatory failure.
TriggersDrugs that induce 5-aminolevulinic acid synthase synthesis (e.g., cotrimoxazole).
PhotodermatosisOccurs due to the formation of active oxygen radicals in the skin upon exposure to light.
NeurotoxicityAssociated with the structural similarity between 5-aminolevulinic acid and GABA.
3 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Classification and causes

Overall, the causes of porphyrias are divided into two categories:

  1. Primary porphyrias. Caused by direct hereditary defects. The problem lies in the structure of the genes themselves that encode the enzymes of the heme synthesis pathway.
  2. Secondary porphyrias. Develop as a consequence of dysregulation in heme synthesis, often under the influence of external factors (e.g., medications).

Mechanism of drug induction (using sulfonamides as an example)

A classic scenario for porphyria exacerbation is the intake of medications such as cotrimoxazole (a sulfonamide). The mechanism of an attack unfolds as a cascade of biochemical reactions:

  • Drug metabolism: Sulfonamides are detoxified in the liver via the cytochrome P450 system, which includes heme as a component.
  • Depletion of reserves: Active functioning of cytochrome P450 requires a constant consumption of heme, leading to a sharp drop in its intracellular concentration.
  • Loss of regulation: Normally, heme acts as an allosteric inhibitor and corepressor of the key enzyme — 5-aminolevulinic acid synthase (ALA synthase). When heme levels drop, depression (removal of the block) of ALA synthase synthesis occurs.
  • Accumulation of metabolites: Increased ALA synthase activity triggers an uncontrolled process. Intermediate synthesis products — 5-aminolevulinic acid, porphobilinogen, and porphyrinogens — accumulate in the blood and tissues in avalanche-like fashion.
Test your knowledge on this topicTasks from the Biochemistry course bank — instant answer and detailed explanation.

Pathogenesis of clinical symptoms

The accumulation of intermediate heme synthesis products explains the entire clinical picture, including the appearance of red urine (due to the excretion of excess porphyrins).

Photosensitization and skin damage (photodermatosis) Excess porphyrinogens are deposited in the skin. Under the influence of ultraviolet light, they turn into porphyrins. These molecules react with oxygen, promoting the formation of reactive oxygen species (ROS) and free radicals that destroy skin cells.

Neurotoxicity Porphyrinogens possess pronounced toxicity toward the nervous system, causing severe neuropsychiatric symptoms. One of the key mechanisms is the structural similarity of the accumulated 5-aminolevulinic acid (ALA) to the major inhibitory neurotransmitter — gamma-aminobutyric acid (GABA).

Briefly: answers to topical questions

Deficiency of which specific enzymes causes various types of primary porphyrias?

Various types of primary porphyrias are caused by genetic defects in the following heme biosynthesis enzymes:

  • ALA dehydratase — ALA dehydratase-deficiency porphyria.
  • Hydroxymethylbilane synthase (including PBG deaminase) — acute intermittent porphyria.
  • Uroporphyrinogen III synthase — congenital erythropoietic porphyria.
  • Uroporphyrinogen decarboxylase — porphyria cutanea tarda.
  • Coproporphyrinogen oxidase — heriditary coproporphyria.
  • Protoporphyrinogen oxidase — variegate porphyria.
  • Ferrochelatase — erythropoietic protoporphyria.

What other drugs, besides sulfonamides (cotrimoxazole), are classic inducers of porphyria?

In addition to sulfonamides, sources indicate the following as inducers of 5-aminolevulinic acid synthase synthesis:

  • Barbiturates and their derivatives — explicitly porphyrogenic drugs; their use in acute porphyrias is contraindicated.
  • Diclofenac.
  • Estrogens.
  • Progestins.

What clinical syndromes (e.g., gastrointestinal), aside from neuropsychiatric disorders and photodermatosis, are characteristic of a porphyria exacerbation?

An acute porphyria attack is characterized by abdominal syndrome. A key symptom is abdominal pain: acute onset, increasing to maximum intensity over 2–3 days; the character and localization can vary widely. Abdominal syndrome can mimic an "acute abdomen": peritoneal signs are absent, and inflammatory laboratory markers are absent in the initial stages. The exact mechanism of pain is unclear; the main theory is autonomic dysfunction, and an alternative is vasoconstriction or intestinal ischemia.

How to memorize

Heme acts as a "brake" for ALA synthase. Cytochrome consumed heme -> brakes failed -> the factory uncontrollably cranks out toxic porphyrins.

Class and exam questions

Why is a porphyria attack often accompanied by skin lesions?

Porphyrinogens accumulate in the skin. In the light, they turn into porphyrins, react with oxygen, and form active radicals that destroy cells.

How are 5-aminolevulinic acid and neuropsychiatric disorders connected?

5-Aminolevulinic acid (ALA) is structurally very similar to GABA — the main inhibitory neurotransmitter, leading to impaired nervous system function.

Why do sulfonamide drugs require heme?

The cytochrome P450 system is actively engaged in the metabolism of sulfonamides. Heme is an essential prosthetic group for cytochrome function.

Something unclear? Ask the AIThe AI tutor has reviewed the material on "Porphyrias" and will explain it in simple terms.

What else to study on this topic

  • Biochemical description of the first two heme synthesis reactions (in mitochondria and cytosol)
  • The role of 5-aminolevulinic acid and porphobilinogen as intermediate products
  • Principles of allosteric enzyme regulation using ALA synthase as an example
  • Structure and functions of the cytochrome P450 system

Master the entire topic in the "Biochemistry" course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Porphyrias" and 3,616 more pages on the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 115 video lessons on the subject

Other topics in the "Heme Metabolism and Iron Metabolism" section

The entire section on "Heme Metabolism and Iron Metabolism"

Free video lessons: biochemistryShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.